PEDIATRICS · 2005 · 91 citations · 14 references
Veterinary MedicineImmunologyPharmacotherapyImmunopathologyImmunotherapyInflammationAirway DiseasesImmunosuppressionImmunosuppressive TherapyObstructive Lung DiseasePulmonary InflammationRespiratory DiseaseBone Marrow InflammationBronchiolitis Obliterans SyndromeBronchiolitis-related Respiratory FailurePost-transplant ImmunosuppressionTumor Necrosis Factor Therapy
Bronchiolitis obliterans (BO) in children is a rare, inflammatory/fibrosing process involving the small airways that often results in progressive, irreversible obstructive pulmonary disease. Because treatment has focused mainly on supportive care and generally unsuccessful immunosuppression, children with BO experience significant morbidity and mortality. We report a case of biopsy-proven BO after bone marrow transplantation in a child who, after failed corticosteroid therapy, was treated with infliximab, a monoclonal antibody with binding specificity for human tumor necrosis factor-alpha. With initiation of treatment, her pulmonary symptoms and radiographic and spirometric evidence of BO resolved. Nine months later, she remains asymptomatic and shows no evidence of pulmonary decompensation. This case illustrates a successful treatment of BO with selective tumor necrosis factor-alpha blockade.
14
Tumor necrosis factor-α blockade for the treatment of acute GVHD
Daniel R. Couriel, Rima M. Saliba, Krystal Hicks et al. · Blood · 2004 · 261 citations · Full text
Marshall I. Hertz, Craig A. Henke, Raouf E. Nakhleh et al. · Proceedings of the National Academy of Sciences · 1992 · 155 citations · Full text
Medicine, Pathobiology, Pathology +12
Bronchiolitis Obliterans in the 1990s in Korea and the United States
Chang Keun Kim, Sang Woo Kim, Joung Sook Kim et al. · CHEST Journal · 2001 · 155 citations